相关实验视频

Updated: Sep 19, 2025

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Published on: November 27, 2016

新的4,5-二二二醇-烯基皮佩拉зин衍生物:合成,对接研究和药理学评估作为血清增强剂

Giorgia Andreozzi¹, Natalia Karkoszka^2,3, Rosa Sparaco¹

¹Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, Via D. Montesano, 80131, Napoli, Italy.

|June 3, 2025

概括

研究人员开发了针对血清素受体的新型arylpiperazine化合物. 包括FG-1在内的几种化合物显示出显著的抗抑郁和抗焦虑作用,而FG-1也显示出抗性质.

科学领域:

药用化学医学化学
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

血清激素受体在调节情绪和行为方面发挥着至关重要的作用.
开发用于血清素受体亚型的选择性配体是治疗神经和精神疾病的关键策略.

研究的目的:

合成和描述一系列新型的长链阿里尔皮佩拉衍生物,作为潜在的血清活性连接剂.
评估这些化合物对5-HT_1A,5-HT_2A和5-HT_2C受体的结合亲和力和选择性.
评估体内功能活动,包括抗抑郁药,焦虑缓解剂和促认知作用,并使用分子对接合理化发现.

主要方法:

新型阿里尔皮佩拉津衍生物的合成 (FG 1-18).
试验室中放射性结定量测试以确定受体亲和性和选择性.
在体内药理学测试以评估抗抑郁药,抗焦虑药和抗药的活性.
分子对接研究以阐明结构-活动关系.

主要成果:

化合物FG-1,FG-4,FG-5,FG-6,FG-7,FG-8和FG-18对5-HT_1A和5-HT_2C受体显示出有希望的亲和力和选择性.
化合物FG-1,FG-5,FG-8和FG-6表现出类似抗抑郁药的作用.
化合物FG-1,FG-18,FG-6和FG-7表现出显著的焦虑缓解特性.
化合物FG-1显示出抗抑郁药,抗焦虑药和抗药的组合.
化合物FG-7和FG-18分别表现出抗焦虑和促认知作用,FG-18具有显著的5-HT_2C受体亲和力.

结论:

合成的arylpiperazine衍生物是具有潜在治疗应用的有效血清激素配体.
化合物FG-1是治疗抑郁症,焦虑症和潜在的有希望的候选物,因为它具有广泛的药理学特征.
化合物FG-7和FG-18需要进一步研究它们的抗焦虑和增强认知特性,特别是它们与5-HT_2C受体的选择性相互作用.

关键词:

(4,5-二二二二) 烯) 皮佩拉辛的存在.具有约束力的测定.连接设计连接设计这种类型的血清素 (serotonin) 是结构活动关系结构活动关系

更多相关视频

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...